Insider Transactions in Q3 2024 at Sage Therapeutics, Inc. (SAGE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2024
|
Christopher Benecchi Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,755
-20.46%
|
$38,040
$8.96 P/Share
|
|
Aug 05
2024
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,200
+41.07%
|
-
|
|
Aug 05
2024
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,503
-15.78%
|
$36,024
$8.96 P/Share
|
|
Aug 05
2024
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+32.11%
|
-
|
|
Aug 05
2024
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,636
-4.28%
|
$29,088
$8.96 P/Share
|
|
Aug 05
2024
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+13.7%
|
-
|
|
Aug 05
2024
|
Laura Gault Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,288
-23.44%
|
$26,304
$8.96 P/Share
|
|
Aug 05
2024
|
Laura Gault Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+49.05%
|
-
|
|
Aug 05
2024
|
Barry E Greene President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,273
-12.61%
|
$98,184
$8.96 P/Share
|
|
Aug 05
2024
|
Barry E Greene President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,400
+34.11%
|
-
|